HomeMy Public PortalAboutTOL PR 2013-04-02 K2M VENADO product launch
Town of Leesburg
News Release
For Immediate Release
Leesburg‐based K2M Strengthens Biologics Portfolio with
Launch of VENADO Bone Graft Systems
Leesburg, VA (April 2, 2013) – K2M, Inc., the world’s leading spinal
device company, recently announced a major expansion of the
company’s U.S. biologics offering with the launch of the VENADO®
Foam Strips and VENADO Granules Bone Graft Systems. K2M, Inc.
is based in Leesburg, Virginia.
VENADO represents an entirely new product family in K2M’s
growing biologics portfolio, already featuring VIKOS® Allograft
Systems and VESUVIUSTM Osteobiologic Systems. The systems are
available in a variety of configurations and sizes specifically
designed to enhance bone regeneration and act as an osteogenic stimulus after spine surgery.
VENADO Foam Strips are purified fibrillar collagen and biphasic granules. The Foam Strips
hydrate quickly in blood or saline, and become very flexible and moldable, yet are less likely to
dissociate or break apart. When bone cells migrate into the graft composite, the implant
functions as a scaffold for osteogenic components. VENADO Granules are a biphasic
combination of hydroxyapatite and beta‐tricalcium phosphate with excellent resorption
characteristics.
According to Dr. Faheem Sandhu, neurosurgeon and Associate Professor at Georgetown
University Hospital, “VENADO provides for synthetic bone graft alternatives for hospitals and
surgeons interested in a non‐allograft solution to the management of complex spinal surgical
issues, and these unique products complement and enhance K2M’s already comprehensive and
innovative spine portfolio.”
“We are excited to bring to market the VENADO Bone Graft Systems and to expand on our
company’s presence in the rapidly growing biologics sector,” stated Eric Major, K2M’s President
and CEO. “The launch of VENADO enables us to meet a significant demand for the high quality
products surgeons have come to expect from K2M.”
“K2M is consistently moving forward in the biologics sector on a global level,” commented
Marantha Edwards, Leesburg’s Economic Development Director. “Their progress is good for
them, good for Leesburg and good for Virginia.”
(more)
TOL PR 2013‐04‐02 K2M VENADO product launch
Page 2
About K2M: K2M, Inc. is the largest privately‐held spinal device company in the world focused
on the research, development, and commercialization of innovative solutions for the treatment
of complex spinal pathologies and minimally invasive procedures. The company is recognized
as a global leader in providing unique technologies for the treatment of deformity,
degenerative, trauma, and tumor spinal patients. K2M’s product development pipeline
includes: spinal stabilization systems, minimally invasive systems, biologics, and other
advancing technologies, such as motion preservation, annular repair, and nucleus replacement.
Additional information is available online at www.K2M.com.
Contacts:
Marcie Kohenak
Zeno Group, on behalf of K2M, Inc.
Marcie.Kohenak@ZenoGroup.com
202‐965‐7811
Marantha Edwards
Economic Development Director
medwards@leesburgva.gov
703‐737‐7019
# # #